Business Standard

Sunday, December 22, 2024 | 06:50 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19 vaccine: Hospitals see no immediate rush for Sputnik Light

Dr Reddy's Laboratories, marketing partner of the Russian Direct Investment Fund for the Sputnik V and Sputnik Light vaccines, has sought government approval for use of Sputnik Light as a booster shot

India is the leading production hub for production of Sputnik vaccine
Premium

Sohini Das Mumbai
The emergency use authorisation for Sputnik Light is unlikely to spark high demand for this single-shot vaccine in the short term, according to hospitals. 

They are of the view that unless newer segments open up for vaccination, demand for Sputnik Light is unlikely to grow.

Dr Reddy’s Laboratories (DRL), the marketing partner of the Russian Direct Investment Fund (RDIF) for the Sputnik V and Sputnik Light vaccines, has sought government approval for the use of Sputnik Light as a booster shot or a precaution dose. It is also in discussions to supply Sputnik Light to public health programmes.

“The current

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in